Ted Mott, Managing Partner of Oxford Capital, and Hadyn Parry, CEO of Oxitec, have been invited to take part in a panel discussion at the British Venture Capital Association’s annual summit on 8th October.
Oxitec was recently acquired by US biotech business Intrexon Corporation, in a deal which valued Oxitec at up to $160m. Oxford Capital supported Oxitec from its early days as a spinout from the University of Oxford, through to its final $10m pre-acquisition funding round.
At the summit, Ted and Hadyn will discuss some of the challenges encountered on the way, as the business grew and we moved towards the eventual exit to Intrexon.
The BVCA Summit is a major private equity and venture capital conference, attended by leading figures from the worlds of business, finance and politics. This year the BVCA expects more than 800 delegates to attend. This year’s speakers include Sir Michael Rake, Chairman of BT Group, Xavier Rolet, Chief Executive of the London Stock Exchange Group, and a host of senior partners from firms across the Private Equity and Venture Capital industries.